Sonoma Pharmaceuticals
SNOA
SNOA
18 hedge funds and large institutions have $825K invested in Sonoma Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$331K | |
| 2 | +$58K | |
| 3 | +$45.7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$6.54K |
Top Sellers
| 1 | -$66K | |
| 2 | -$60K | |
| 3 | -$56.9K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$26.6K |
| 5 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$22K |